NCT06480071View on ClinicalTrials.gov

The Role of Nasal Breathing for Perfomance in Elite Athletes.

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 13, 2022

Primary Completion Date

March 17, 2022

Study Completion Date

March 17, 2022

Conditions
Breathing, Mouth
Interventions
DRUG

Oxymetazoline, 0.05% Nasal Spray

2 sprays each nostril before the excercise test.

Trial Locations (1)

41345

Department of ENT Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Sahlgrenska University Hospital

OTHER